Ark Clinical Research - Fountain Valley

Fountain Valley, California 92708

8 studies enrolling now · 10 studies all time

What they study most

Alcohol Use Disorder, Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Low Back Pain (CLBP), Cortisol Excess, Elevated Lp(a), Metabolic Dysfunction-Associated SteatoHepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis, Obesity, Opioid Use Disorder, Osteoarthritis, Overweight

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• A Study of Brenipatide in Participants With Opioid Use Disorder — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) — Recruiting now
• A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes — Recruiting now
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight — Recruiting now
• A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition — Recruiting now
• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Recruiting now
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain — Running, not enrolling
• A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder — Completed